Company profile
Latest filings (excl ownership)
SC TO-T/A
Third party tender offer statement (amended)
13 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
5 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
5 Oct 20
CORRESP
Correspondence with SEC
5 Oct 20
SC TO-T/A
Third party tender offer statement (amended)
29 Sep 20
CORRESP
Correspondence with SEC
29 Sep 20
SC TO-T/A
Third party tender offer statement (amended)
21 Sep 20
SC TO-T
Third party tender offer statement
14 Sep 20
SC TO-C
Information about tender offer
14 Sep 20
SC TO-C
Information about tender offer
31 Aug 20
Latest ownership filings
SC 13G/A
Axcella Health Inc.
2 Feb 23
SC 13G
ChromaDex Corp.
19 Oct 22
4
Axcella Health Inc.
17 Oct 22
4
Axcella Health Inc.
16 Mar 22
3
Prometheus Biosciences, Inc.
12 Mar 21
SC 13G/A
Axcella Health Inc.
12 Feb 21
4
Aimmune Therapeutics, Inc.
15 Oct 20
SC 13D/A
Aimmune Therapeutics, Inc.
13 Oct 20
4
Axcella Health Inc.
9 Sep 20
SC 13D/A
Aimmune Therapeutics, Inc.
31 Aug 20
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
13 Oct 22 | Societe des Produits Nestle | Common Stock | Buy | Acquire P | Yes | No | 1.64 | 3,658,536 | 6.00 mm | 11,105,438 |